Blog

by Vineti | August 8, 2019
Here are a few of the notable cell therapy and gene therapy updates from the past month.

by Amy DuRoss | July 30, 2019
While every day we seek to bring kaizen to cell and gene therapy,  we still have an important first step to accomplish as an industry (as we all know) -- standardization.  Without standardization, we can’t optimize or achieve truly “lean”…

by Amy DuRoss | July 22, 2019
In cell therapy, gene therapy, and personalized cancer vaccines, most media coverage understandably focuses on the medicine. But as the field of personalized therapeutics expands, a few authors are catching on to the fact that other innovations --…

by Marc Puich | July 10, 2019
Previously in this series, we discussed the Strategy, the Operational Ecosystem, and the Processes needed to establish an effective personalized medicine supply chain. Now, we’ll turn our attention to one more essential component -- managing risks…

by Amy DuRoss | July 1, 2019
Each year, the World Economic Forum welcomes leading early-stage companies from around the world into its Technology Pioneers community. Today, I’m both thrilled and humbled to share the news that Vineti has been named a global Technology Pioneer in…

Subscribe to our blog
Required
Required
Required
Required
Required
Required
Required
Required